Electromed (ELMD) Cash & Equivalents (2010 - 2026)

Electromed (ELMD) has reported Cash & Equivalents for 17 consecutive years, with $17.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 11.47% year-over-year to $17.0 million; the TTM figure through Mar 2026 stood at $17.0 million (up 11.47% YoY), while the FY2025 annual figure was $15.3 million, down 4.93% from the prior year.
• Cash & Equivalents improved to $17.0 million in Q1 2026 per ELMD's latest filing, from $13.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $17.0 million in Q1 2026 and bottomed at $6.0 million in Q3 2022.
• Historically, Cash & Equivalents has averaged $11.5 million across 5 years, with a median of $11.7 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 45.37% — and 2024, when it jumped 118.12%.
• Electromed's Cash & Equivalents stood at $6.9 million in 2022, then surged by 51.02% to $10.4 million in 2023, then soared by 55.6% to $16.2 million in 2024, then retreated by 15.05% to $13.8 million in 2025, then increased by 23.16% to $17.0 million in 2026.
• Business Quant data shows ELMD's Cash & Equivalents at $17.0 million in Q1 2026, $13.8 million in Q4 2025, and $14.1 million in Q3 2025.